Integrating Serum Biomarkers and Genetic Polymorphisms for Enhanced Alzheimers Disease Risk Screening
Li, Z.; Feng, Z.; He, S.; Tang, H.; Zhao, C.; Liu, J.; Su, Y.; Duan, J.; Tian, X.; Yan, Y.; Shi, X.; Bi, X.
Show abstract
ObjectiveAnalyze the differences in the detection results of Alzheimers disease (AD) serum biomarkers and the expression of APOE and SLCO1B1 genotypes, then construct an AD diagnostic model integrating serum biomarkers with APOE and SLCO1B1 genotypes to enhance the sensitivity and specificity of AD screening. MethodsSerum samples from 127 participants (41 AD, 39 cognitive impairments, 47 controls) were analyzed for neurofilament light chain (NF), A{beta}42/A{beta}40 ratio, p-TAU231, and p-TAU217 via ELISA, combined with APOE/SLCO1B1 genotyping. A nomogram model was constructed using logistic regression and validated by ROC-AUC and Hosmer-Lemeshow tests. ResultsThe AD group showed elevated NF (p<0.01) and p-TAU231 (p<0.05), reduced A{beta}42/A{beta}40 (p<0.05). APOE {varepsilon}4 homozygotes exhibited the highest p-TAU181 (p<0.001), while SLCO1B1*1b/*1b correlated with increased A{beta}42 (p<0.05). The biomarker model achieved AUC=0.8365, improving to 0.8832 after genetic integration (calibration p>0.05). ConclusionThis study pioneers an AD diagnostic model combining serum p-TAU231, NF, and SLCO1B1 polymorphisms, surpassing single-marker limitations (AUC>0.88). It provides a high-accuracy tool for non-invasive screening and genetic stratification, demonstrating substantial clinical potential.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease 98%
- Plasma biomarkers identify brain ATN abnormalities in a dementia-free population-based cohort 97%
- White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer’s disease continuum 95%
Similar papers in this journal
- Differences between plasma and CSF p-tau181 and p-tau231 in early Alzheimer’s disease 98%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 97%
- Disentangling the distal association between β-Amyloid and tau pathology at varying stages of tau deposition 96%
Similar papers in this journal
- Common molecular signatures between coronavirus infection and Alzheimer's disease reveal targets for drug development 97%
- Association of GLOD4 with Alzheimers Disease in Humans and Mice 96%
- Targeted Serum Metabolomic Profiling and Machine Learning Approach in Alzheimer’s Disease using the Alzheimer’s Disease Diagnostics Clinical Study (ADDIA) Cohort 96%
Similar papers in this journal
- A conformational variant of p53 (U-p53 AZ ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease 96%
- Identifying Proteomic Prognostic Markers for Alzheimer’s Disease with Survival Machine Learning: the Framingham Heart Study 96%
- Plasma brain-derived p-tau217 outperforms other p-tau species in detecting abnormal brain amyloid in an Asian cohort of older people with cerebrovascular disease burden 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.